<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen TJ</submitter><funding>National Natural Science Foundation of China</funding><pagination>549037</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7768012</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14</volume><pubmed_abstract>Previous studies have reported the anti-oxidant, anti-inflammatory, and anti-cancer effects of fisetin. However, the therapeutic efficacy of fisetin in Parkinson's disease (PD) is unclear. In this study, we demonstrated that fisetin could markedly alleviate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in mice. To confirm the reported correlation between gut microbiota and PD, the bacterial DNA in the fresh feces of mice from each group was subjected to 16S rRNA (V3 and V4 regions) sequencing. The results revealed that fisetin changed the number, diversity, and distribution of gut microbiota in MPTP-induced mice model of PD. The alpha and beta diversity analyses showed that the fisetin intervented MPTP group gut microbiota exhibited a significan</pubmed_abstract><journal>Frontiers in neuroscience</journal><pubmed_title>Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease.</pubmed_title><pmcid>PMC7768012</pmcid><funding_grant_id>81671251</funding_grant_id><funding_grant_id>81971185</funding_grant_id><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Chen TJ</pubmed_authors><pubmed_authors>Wu YC</pubmed_authors><pubmed_authors>Feng Y</pubmed_authors><pubmed_authors>Chen YJ</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Liu T</pubmed_authors><pubmed_authors>Wu TT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fisetin Regulates Gut Microbiota and Exerts Neuroprotective Effect on Mouse Model of Parkinson's Disease.</name><description>Previous studies have reported the anti-oxidant, anti-inflammatory, and anti-cancer effects of fisetin. However, the therapeutic efficacy of fisetin in Parkinson's disease (PD) is unclear. In this study, we demonstrated that fisetin could markedly alleviate 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in mice. To confirm the reported correlation between gut microbiota and PD, the bacterial DNA in the fresh feces of mice from each group was subjected to 16S rRNA (V3 and V4 regions) sequencing. The results revealed that fisetin changed the number, diversity, and distribution of gut microbiota in MPTP-induced mice model of PD. The alpha and beta diversity analyses showed that the fisetin intervented MPTP group gut microbiota exhibited a significan</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-04-27T00:02:22.549Z</modification><creation>2025-04-06T17:41:02.624Z</creation></dates><accession>S-EPMC7768012</accession><cross_references><pubmed>33381005</pubmed><doi>10.3389/fnins.2020.549037</doi></cross_references></HashMap>